Diuretics, Mortality, and Nonrecovery of Renal Function in Acute Renal Failure | Acute Kidney Injury | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.238.77. Please contact the publisher to request reinstatement.
1.
Klahr S, Miller SB. Acute oliguria.  N Engl J Med.1998;338:671-675.Google Scholar
2.
Sladen RN. Oliguria in the ICU: systematic approach to diagnosis and treatment.  Anesthesiol Clin North America.2000;18:739-752, viii.Google Scholar
3.
Bellomo R, Ronco C. Indications and criteria for initiating renal replacement therapy in the intensive care unit.  Kidney Int Suppl.1998;66:S106-S109.Google Scholar
4.
Wilson WC, Aronson S. Oliguria: a sign of renal success or impending renal failure?  Anesthesiol Clin North America.2001;19:841-883.Google Scholar
5.
Anderson RJ, Linas SL, Berns AS.  et al.  Nonoliguric acute renal failure.  N Engl J Med.1977;296:1134-1138.Google Scholar
6.
Diamond JR, Yoburn DC. Nonoliguric acute renal failure.  Arch Intern Med.1982;142:1882-1884.Google Scholar
7.
Brown RS. Renal dysfunction in the surgical patient: maintenance of high output state with furosemide.  Crit Care Med.1979;7:63-68.Google Scholar
8.
Gerlach AT, Pickworth KK. Contrast medium-induced nephrotoxicity: pathophysiology and prevention.  Pharmacotherapy.2000;20:540-548.Google Scholar
9.
Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents.  N Engl J Med.1994;331:1416-1420.Google Scholar
10.
Weinstein JM, Heyman S, Brezis M. Potential deleterious effect of furosemide in radiocontrast nephropathy.  Nephron.1992;62:413-415.Google Scholar
11.
Davidman M, Olson P, Kohen J, Leither T, Kjellstrand C. Iatrogenic renal disease.  Arch Intern Med.1991;151:1809-1812.Google Scholar
12.
Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery.  J Am Soc Nephrol.2000;11:97-104.Google Scholar
13.
Visweswaran P, Massin EK, Dubose Jr TD. Mannitol-induced acute renal failure.  J Am Soc Nephrol.1997;8:1028-1033.Google Scholar
14.
Brown CB, Ogg CS, Cameron JS. High dose furosemide in acute renal failure: a controlled trial.  Clin Nephrol.1981;15:90-96.Google Scholar
15.
Kleinknecht D, Ganeval D, Gonzalez-Duque LA, Fermanian J. Furosemide in acute oliguric renal failure: a controlled trial.  Nephron.1976;17:51-58.Google Scholar
16.
Gubern JM, Sancho JJ, Simo J, Sitges-Serra A. A randomized trial on the effect of mannitol on postoperative renal function in patients with obstructive jaundice.  Surgery.1988;103:39-44.Google Scholar
17.
Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study.  Nephrol Dial Transplant.1997;12:2592-2596.Google Scholar
18.
Chang RW, Jacobs S, Lee B, Pace N. Predicting deaths among intensive care unit patients.  Crit Care Med.1988;16:34-42.Google Scholar
19.
Mehta RL, McDonald B, Gabbai FB.  et al.  A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure.  Kidney Int.2001;60:1154-1163.Google Scholar
20.
Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve.  Radiology.1982;143:29-36.Google Scholar
21.
Lemeshow S, Hosmer Jr DW. A review of goodness of fit statistics for use in the development of logistic regression models.  Am J Epidemiol.1982;115:92-106.Google Scholar
22.
Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score.  J Am Stat Assoc.1984;79:516-524.Google Scholar
23.
Kaplan E, Meier P. Nonparametric estimation from incomplete observations.  J Am Stat Assoc.1958;53:457-481.Google Scholar
24.
Mehta RL, Pascual MT, Gruta CG, Zhuang S, Chertow GM. Refining predictive models in critically ill patients with acute renal failure.  J Am Soc Nephrol.2002;13:1350-1357.Google Scholar
25.
Kellum JA. Diuretics in acute renal failure: protective or deleterious?  Blood Purif.1997;15:319-322.Google Scholar
26.
Venkataram R, Kellum JA. The role of diuretic agents in the management of acute renal failure.  Contrib Nephrol.2001;(132):158-170.Google Scholar
27.
Kellum JA. The use of diuretics and dopamine in acute renal failure: a systematic review of the evidence.  Crit Care (Lond).1997;1:53-59.Google Scholar
28.
Lewis J, Salem MM, Chertow GM.  et al. for the Anaritide Acute Renal Failure Study Group.  Atrial natriuretic factor in oliguric acute renal failure.  Am J Kidney Dis.2000;36:767-774.Google Scholar
29.
Bullock ML, Umen AJ, Finkelstein M, Keane WF. The assessment of risk factors in 462 patients with acute renal failure.  Am J Kidney Dis.1985;5:97-103.Google Scholar
30.
Liano F, Gallego A, Pascual J.  et al.  Prognosis of acute tubular necrosis: an extended prospectively contrasted study.  Nephron.1993;63:21-31.Google Scholar
31.
McCarthy JT. Prognosis of patients with acute renal failure in the intensive-care unit: a tale of two eras.  Mayo Clin Proc.1996;71:117-126.Google Scholar
32.
Chertow GM, Lazarus JM, Paganini EP.  et al. for the Auriculin Anaritide Acute Renal Failure Study Group.  Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis.  J Am Soc Nephrol.1998;9:692-698.Google Scholar
33.
Liano F, Pascual J. Outcomes in acute renal failure.  Semin Nephrol.1998;18:541-550.Google Scholar
34.
Mehta RL, McDonald B, Gabbai FB.  et al.  Nephrology consultation in acute renal failure: does timing matter?  Am J Med.2002;113:456-461.Google Scholar
35.
Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: a cohort analysis.  JAMA.1996;275:1489-1494.Google Scholar
36.
Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery.  Am J Med.1998;104:343-348.Google Scholar
37.
Bates DW, Su L, Yu DT.  et al.  Mortality and costs of acute renal failure associated with amphotericin B therapy.  Clin Infect Dis.2001;32:686-693.Google Scholar
38.
Cantarovich F, Verho MT. A simple prognostic index for patients with acute renal failure requiring dialysis: French multicentric prospective study on furosemide in acute renal failure requiring dialysis.  Ren Fail.1996;18:585-592.Google Scholar
39.
Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J.for the Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.  Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial.  Lancet.2000;356:2139-2143.Google Scholar
Original Contribution
November 27, 2002

Diuretics, Mortality, and Nonrecovery of Renal Function in Acute Renal Failure

Author Affiliations

Author Affiliations: Division of Nephrology, University of California, San Diego, Medical Center (Dr Mehta and Mss Pascual and Soroko); and Divisions of Nephrology, Moffitt-Long Hospitals and UCSF–Mt Zion Medical Center, University of California, San Francisco (Dr Chertow).

JAMA. 2002;288(20):2547-2553. doi:10.1001/jama.288.20.2547
Abstract

Context Acute renal failure is associated with high mortality and morbidity. Diuretic agents continue to be used in this setting despite a lack of evidence supporting their benefit.

Objective To determine whether the use of diuretics is associated with adverse or favorable outcomes in critically ill patients with acute renal failure.

Design Cohort study conducted from October 1989 to September 1995.

Patients and Setting A total of 552 patients with acute renal failure in intensive care units at 4 academic medical centers affiliated with the University of California. Patients were categorized by the use of diuretics on the day of nephrology consultation and, in companion analyses, by diuretic use at any time during the first week following consultation.

Main Outcome Measures All-cause hospital mortality, nonrecovery of renal function, and the combined outcome of death or nonrecovery.

Results Diuretics were used in 326 patients (59%) at the time of nephrology consultation. Patients treated with diuretics on or before the day of consultation were older and more likely to have a history of congestive heart failure, nephrotoxic (rather than ischemic or multifactorial) origin of acute renal failure, acute respiratory failure, and lower serum urea nitrogen concentrations. With adjustment for relevant covariates and propensity scores, diuretic use was associated with a significant increase in the risk of death or nonrecovery of renal function (odds ratio, 1.77; 95% confidence interval, 1.14-2.76). The risk was magnified (odds ratio, 3.12; 95% confidence interval, 1.73-5.62) when patients who died within the first week following consultation were excluded. The increased risk was borne largely by patients who were relatively unresponsive to diuretics.

Conclusions The use of diuretics in critically ill patients with acute renal failure was associated with an increased risk of death and nonrecovery of renal function. Although observational data prohibit causal inference, it is unlikely that diuretics afford any material benefit in this clinical setting. In the absence of compelling contradictory data from a randomized, blinded clinical trial, the widespread use of diuretics in critically ill patients with acute renal failure should be discouraged.

×